US Patent 12110327 Anti-TREM1 antibodies and methods of use thereof
Patent 12110327 was granted and assigned to Alector on October, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+24 properties)
Article (+358 characters)
US Patent 12110327 Anti-TREM1 antibodies and methods of use thereof
Article
Patent abstract
The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a TREM1 protein, e.g., a mammalian TREM1 or human TREM1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrew Pincetic0
Arnon Rosenthal0
Francesca Avogadri-Connors0
Helen Lam0
Seung-Joo Lee0
Date of Patent
October 8, 2024
0Patent Application Number
179317570
Date Filed
September 13, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12110327 Anti-TREM1 antibodies and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
